Sanofi’s dupilumab joins UK’s early access scheme
admin 14th March 2017 Uncategorised 0Patients with atopic dermatitis are to get early access to Sanofi’s dupilumab before its marketing authorisation in the UK, after the Medicines and Healthcare Products Regulatory Agency issued a positive scientific opinion for the drug through the country’s Early Access to Medicines Scheme.
More: Sanofi’s dupilumab joins UK’s early access scheme
Source: News